期刊文献+

多发性硬化患者血清、脑脊液IL-12、TNF-α、IFN-γ及cICAM-1水平变化 被引量:1

The Changes of IL-12,TNF-α,IFN-γ and cICAM-1 in Serum and CSF of Patients with Multiple Sclerosis
下载PDF
导出
摘要 目的观察多发性硬化(MS)患者血清、脑脊液(CSF)中可溶性细胞间黏附分子(cICAM-1)、肿瘤坏死因子-α(TNF-α)及干扰素-γ(IFN-γ)的水平,以及经白细胞介素-12(IL-12)刺激后上述因子水平的变化。方法采用ELISA法检测MS及其他疾病组(OND)患者血清、CSF中TNF-α、IFN-γ及cICAM-1水平并观察IL-12刺激前后TNF-α、IFN-γ及cICAM-1水平变化。结果MS组CSF及血清中TNF-α水平[(313.8±65.5)pg/mL,(127.9±57.3)pg/mL]较OND组[(21.9±3.3)pg/mL,(30.8±10.1)pg/mL]高,差异有统计学意义(分别为P<0.01,P<0.05);MS组CSF及血清中IFN-γ水平[(231.4±57.3)pg/mL,(189.4±69.3)pg/mL]均较OND组[(87.4±21.3)pg/mL,(98.4±23.2)pg/mL]高,差异有统计学意义(分别为P<0.01,P<0.05);MS组血清中cICAM-1水平[(105.9±56.2)U/mL]明显高于OND组[(50.9±20.3)U/mL],差异有统计学意义(P<0.05)。经IL-12刺激后MS组上清液中TNF-α[(252.8±69.7)pg/mL]、IFN-γ[(459.8±69.3)pg/mL]及cICAM-1[(207.6±75.4)U/mL]水平较OND组[(132.4±46.3)pg/mL,(221.8±55.6)pg/mL,(87.5±44.2)U/mL]明显增高,差异有统计学意义(均P<0.05)。结论TNF-α、IFN-γ及cICAM-1在MS发病机制中起一定作用,IL-12、IFN-γ及cICAM-1间可能存在协同作用。 Objective To observe the levels of cICAM-1,TNF-α and IFN-γ in patients with Multiple sclerosis (MS) and to investigate the changed levels of above cytokins after stimulated by IL-12. Methods To detect the changes of TNF-α,IFN-γ ,cICAM-1 levels in serum and CSF of MS and other neurologic diseases (OND) groups by enzyme linked immunosorbent assay (ELISA). Results The concentration of TNF-α in CSF and serum of MS group [(313.8±65.5)pg/mL, (127.9±57.3)pg/mL] is higher than that of OND group [(21.9±3.3)pg/mL, (30.8±10.1)pg/mL], the difference is statistically significant (P〈0.01, P〈0.05 ); The concentration of IFN-γ in CSF and serum of MS group [(231.4±57.3)pg/mL, (189.4±69.3)pg/mL] is higher than that of OND group [(87.4±21.3)pg/mL, (98.4±23.2)pg/mL], The difference is statistically significant (P〈0.01, P〈0.05 ); The concentration of cICAM-1 in serum of MS group [(105.9±56.2)U/mL] is higher than that of OND group [( 50.9±20.3)U/mL], the difference is statistically significant (P〈0.05). The level of TNF-α[(252.8±69.7)pg/mL], IFN-γ[(459.8±69.3)pg/mL] and cICAM-1 [(207.6±75.4)U/mL] in MS patient supernatant is higher than that of OND after stimulated by IL-12, the difference is statistically significant (P〈0.05). Conclusions TNF-α,IFN-γ and clCAM-1 is very important in pathogenic mechanism, meanwhile, IL-12, IFN-γ and cICAM-1 have synergetic effect.
出处 《中国神经免疫学和神经病学杂志》 CAS 2007年第5期246-248,共3页 Chinese Journal of Neuroimmunology and Neurology
基金 哈尔滨市科委自然科学基金资助项目(D200501)
关键词 多发性硬化 细胞因子 黏附分子 multiple sclerosis cytokine adhesion molecule
  • 相关文献

参考文献7

  • 1Ruddle NH,Bergman CM,McGrath KM,et al.An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis?[J].Exp Med,1990,172(4):1193-1200. 被引量:1
  • 2Wang X,Chen M,Wandinger KP,et al.IFN-γ beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism:revelance to IFN-γ beta-1b therapeutic effects in multiple sclerosis[J].Immunology,2000,165:548-557. 被引量:1
  • 3Barten DM,Ruddle NH.Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis[J].Neuroimmunology,1994,51(2):123-133. 被引量:1
  • 4Hurwitz AA,Lyman WD,Guida MP,et al.Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes[J].Exp Med,1992,176(6):1631-1636. 被引量:1
  • 5Karp CL,Biron CA,Irani DN.Iterferon beta in multiple sclerosis:is IL-12 supression the key?[J].Immunol Today,2000,21(1):24-28. 被引量:1
  • 6Ferrante P,Fusi ML,Seresella M,et al.Cytokine production and surface marker expression in acute and stable multiple sclerosis:altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis[J].Immunology,1998;160:1514-1521. 被引量:1
  • 7Constantinescu CS,Wysocka M,Hilliard B,et al.Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis[J].Immunology,1998,161:5097-5104. 被引量:1

同被引文献6

  • 1Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome[J]. Ann Neurol, 1990, 27(Suppl) : S21-24. 被引量:1
  • 2Hughes RA, Cornblath DR. Guillain-Barre syndrome [J]. Lancet, 2005, 366(9497): 1653-1666. 被引量:1
  • 3Bao L,Lindgren JU,van der Meide P, etal. The critical role of IL-12p40 in initiating,enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis[J]. Brain Pathol, 2002, 12(4): 420-429. 被引量:1
  • 4Zhu W, Mix E, Zhu J. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats[J]. J Neuroimmunol, 2003, 140(1-2): 97- 101. 被引量:1
  • 5Radhakrishnan VV, Sumi MG, Reuben S, et al. Serum tumour necrosis factor-α and soluble tumour necrosis factor receptors levels in patients with Guillain- Barre syndrome[J].Acta Neurol Scand, 2004, 109 (1): 71-74. 被引量:1
  • 6Hughes RA, Swan AV, Raphael JC, et al. Immunotherapy for Guillain-Barre syndrome: a systematic review[J]. Brain, 2007, 130: 2245-2257. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部